Sara G Danielli

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Skeletal Muscle

Top Venues

Molecular cancer therapeutics

Science advances

Nature communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular cancer therapeutics 23 (6) (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the role of AXL in fusion-positive pediatric rhabdomyosarcoma identifies the small-molecule inhibitor bemcentinib (BGB324) as potent chemosensitizer. Molecular cancer therapeutics (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular cancer therapeutics 23 (6) (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular cancer therapeutics 23 (6) (2024)
Sara G Danielli, Yun Wei, Michael A Dyer, Elizabeth A Stewart, Heather S Sheppard, Marco Wachtel, Beat W Schäfer, Anand G Patel, David M Langenau
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma. Nature communications 15 (1) (2024)
Sara G Danielli, Jakob Wurth, Sarah Morice, Samanta Kisele, Didier Surdez, Olivier O Delattre, Peter Karl Bode, Marco Wachtel, Beat W Schäfer
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer. Molecular cancer therapeutics 23 (6) (2024)
Sara G Danielli, Yun Wei, Michael A Dyer, Elizabeth A Stewart, Heather S Sheppard, Marco Wachtel, Beat W Schäfer, Anand G Patel, David M Langenau
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma. Nature communications 15 (1) (2024)
Sara G Danielli, Yun Wei, Michael A Dyer, Elizabeth A Stewart, Heather S Sheppard, Marco Wachtel, Beat W Schäfer, Anand G Patel, David M Langenau
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma. Nature communications 15 (1) (2024)
Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G Marques, Stephanie Kasper, Peter Karl Bode, Anton G Henssen, Dennis Gurgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M Blau, Marco Wachtel, Beat W Schäfer
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science advances 9 (6) (2023)
Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G Marques, Stephanie Kasper, Peter Karl Bode, Anton G Henssen, Dennis Gurgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M Blau, Marco Wachtel, Beat W Schäfer
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science advances 9 (6) (2023)
Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G Marques, Stephanie Kasper, Peter Karl Bode, Anton G Henssen, Dennis Gurgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M Blau, Marco Wachtel, Beat W Schäfer
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science advances 9 (6) (2023)
Silvia Pomella, Sara G Danielli, Rita Alaggio, Willemijn B Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S Walters, Beat W Schäfer, Rossella Rota, Janet M Shipley, Simone Hettmer
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. Cancers 15 (10) (2023)
Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G Marques, Stephanie Kasper, Peter Karl Bode, Anton G Henssen, Dennis Gurgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M Blau, Marco Wachtel, Beat W Schäfer
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science advances 9 (6) (2023)
Olivia Ruhen, Nathalie S M Lak, Janine Stutterheim, Sara G Danielli, Mathieu Chicard, Yasmine Iddir, Alexandra Saint-Charles, Virginia Di Paolo, Lucia Tombolan, Susanne Andrea Gatz, Ewa Aladowicz, Paula Proszek, Sabri Jamal, Reda Stankunaite, Deborah Hughes, Paul Carter, Elisa Izquierdo, Ajla Wasti, Julia C Chisholm, Sally L George, Erika Pace, Louis Chesler, Isabelle Aerts, Gaëlle Pierron, Sakina Zaidi, Olivier Delattre, Didier Surdez, Anna Kelsey, Michael Hubank, Paolo Bonvini, Gianni Bisogno, Angela Di Giannatale, Gudrun Schleiermacher, Beat W Schäfer, Godelieve A M Tytgat, Janet Shipley
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study. JCO precision oncology 6 (2022)